Aurinia Pharmaceuticals Inc.
NASDAQ:AUPH
8.32 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 175.513 | 134.03 | 45.605 | 50.118 | 0.318 | 0.463 | 0.42 | 0.173 | 0.235 | 0.278 | 0.949 | 6.158 | 0.928 | 3.42 | 4.052 | 3.877 | 2.335 | 3.523 | 1.178 | 1.274 | 7.661 | 11.917 | 5.297 | 0.903 | 1.358 | 0.781 |
| Cost of Revenue
| 14.148 | 5.664 | 1.091 | 50.327 | 52.866 | 41.382 | 0.001 | 0.004 | 0.012 | 0.037 | 0.001 | 0.046 | 0.185 | 0.051 | 0.576 | 2.115 | 1.05 | 0.597 | 0 | 0 | 0 | 0.686 | 1.025 | 0.681 | 0.679 | 0.521 |
| Gross Profit
| 161.365 | 128.366 | 44.514 | -0.209 | -52.548 | -40.919 | 0.419 | 0.169 | 0.223 | 0.241 | 0.948 | 6.112 | 0.742 | 3.369 | 3.476 | 1.762 | 1.284 | 2.926 | 1.178 | 1.274 | 7.661 | 11.231 | 4.272 | 0.222 | 0.679 | 0.26 |
| Gross Profit Ratio
| 0.919 | 0.958 | 0.976 | -0.004 | -165.245 | -88.378 | 0.998 | 0.977 | 0.949 | 0.867 | 0.999 | 0.992 | 0.8 | 0.985 | 0.858 | 0.454 | 0.55 | 0.83 | 1 | 1 | 1 | 0.942 | 0.806 | 0.246 | 0.5 | 0.333 |
| Reseach & Development Expenses
| 49.641 | 44.988 | 51.139 | 50.327 | 52.866 | 41.382 | 33.93 | 14.534 | 15.982 | 9.112 | 1.934 | 5.509 | 3.476 | 3.989 | 7.652 | 11.443 | 29.697 | 19.004 | 19.445 | 13.52 | 9.123 | 7.106 | 8.41 | 4.778 | 1.426 | 1.432 |
| General & Administrative Expenses
| 195.036 | 196.371 | 171.438 | 95.983 | 22.154 | 13.674 | 12.096 | 6.97 | 6.263 | 6.89 | 2.231 | 3.902 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 195.036 | 196.371 | 171.438 | 95.983 | 22.154 | 13.674 | 12.096 | 6.97 | 6.263 | 6.89 | 2.231 | 3.902 | 2.744 | 3.267 | 3.61 | 4.539 | 5.711 | 6.193 | 9.783 | 7.85 | 8.332 | 4.966 | 3.053 | 1.773 | 1.019 | 1.367 |
| Other Expenses
| 8.379 | -1.523 | 2.672 | 1.289 | 1.548 | 2.065 | 0.195 | -1.63 | -0.337 | -0.848 | -4.207 | 2.168 | 4.023 | -0.425 | 2.448 | 0.478 | 1.9 | 1.881 | 2.239 | 3.062 | 1.423 | 0.702 | 0.339 | 0.411 | -0.543 | 0.13 |
| Operating Expenses
| 244.677 | 239.836 | 225.249 | 147.599 | 76.568 | 56.621 | 47.482 | 22.983 | 23.803 | 17.523 | 4.979 | 11.58 | 7.181 | 8.416 | 12.494 | 17.38 | 37.309 | 27.079 | 31.467 | 24.432 | 18.878 | 12.774 | 11.802 | 6.962 | 1.901 | 2.93 |
| Operating Income
| -83.312 | -111.47 | -180.735 | -104.29 | -82.539 | -56.158 | -47.063 | -22.814 | -23.58 | -17.282 | -5.505 | -5.468 | -6.439 | -5.046 | -10.046 | -16.36 | -36.024 | -24.153 | -30.289 | -23.159 | -11.217 | -1.543 | -7.53 | -6.74 | -1.222 | -2.669 |
| Operating Income Ratio
| -0.475 | -0.832 | -3.963 | -2.081 | -259.557 | -121.292 | -112.055 | -131.873 | -100.34 | -62.165 | -5.804 | -0.888 | -6.942 | -1.475 | -2.479 | -4.22 | -15.43 | -6.857 | -25.715 | -18.184 | -1.464 | -0.129 | -1.421 | -7.466 | -0.9 | -3.417 |
| Total Other Income Expenses Net
| 5.843 | 5.118 | 0.529 | 1.516 | -41.163 | -7.889 | -23.729 | -0.508 | 4.923 | 0.6 | -2.274 | -4.176 | 4.023 | -0.425 | 2.448 | 0.478 | 2.206 | 1.238 | 1.494 | 0.033 | -3.303 | 1.249 | 0.18 | 0.005 | 0 | 0.326 |
| Income Before Tax
| -77.469 | -106.352 | -180.206 | -102.774 | -123.702 | -64.047 | -70.792 | -23.295 | -18.607 | -16.647 | -6.402 | -9.738 | -2.407 | -5.459 | -7.598 | -15.882 | -33.822 | -22.853 | -29.074 | -22.556 | -14.52 | -0.294 | -7.349 | -6.271 | 0 | -2.344 |
| Income Before Tax Ratio
| -0.441 | -0.793 | -3.951 | -2.051 | -389 | -138.33 | -168.552 | -134.653 | -79.179 | -59.881 | -6.75 | -1.581 | -2.596 | -1.596 | -1.875 | -4.097 | -14.487 | -6.488 | -24.683 | -17.711 | -1.895 | -0.025 | -1.387 | -6.947 | 0 | -3 |
| Income Tax Expense
| 0.551 | 1.828 | 0.76 | -0.094 | 0.144 | 0.073 | 23.924 | 0.481 | -4.973 | 0.03 | -3.856 | 0.055 | 4.024 | 0.101 | 1.029 | 0.741 | 0.35 | -0.001 | 0.001 | 0.003 | 0.126 | 0.072 | 0.055 | 0.014 | -0 | -0.13 |
| Net Income
| -78.02 | -108.18 | -180.966 | -102.68 | -123.846 | -64.12 | -70.792 | -23.295 | -18.607 | -16.647 | -2.546 | -9.737 | -2.407 | -3.66 | -7.598 | -15.882 | -33.822 | -22.853 | -29.075 | -22.56 | -14.646 | -0.366 | -7.405 | -6.285 | -1.222 | -2.214 |
| Net Income Ratio
| -0.445 | -0.807 | -3.968 | -2.049 | -389.453 | -138.488 | -168.552 | -134.653 | -79.179 | -59.881 | -2.684 | -1.581 | -2.596 | -1.07 | -1.875 | -4.097 | -14.487 | -6.487 | -24.684 | -17.714 | -1.912 | -0.031 | -1.398 | -6.962 | -0.9 | -2.833 |
| EPS
| -0.54 | -0.76 | -1.4 | -0.87 | -1.33 | -0.76 | -0.92 | -0.66 | -0.58 | -0.57 | -0.4 | -2.74 | -0.7 | -1.44 | -3.17 | -7.47 | -16.34 | -13.73 | -18.51 | -14.97 | -10.41 | -0.32 | -7.22 | -8.39 | -2.25 | -4.56 |
| EPS Diluted
| -0.54 | -0.76 | -1.4 | -0.87 | -1.33 | -0.76 | -0.92 | -0.66 | -0.58 | -0.57 | -0.4 | -2.74 | -0.7 | -1.44 | -3.17 | -7.47 | -16.34 | -13.56 | -18.39 | -14.96 | -10.41 | -0.28 | -7.22 | -8.39 | -2.25 | -4.56 |
| EBITDA
| -71.665 | -111.47 | -178.637 | -96.192 | -80.991 | -44.639 | -21.683 | -20.827 | -26.945 | -15.696 | -3.215 | -4.655 | -1.446 | -4.312 | -7.742 | -14.217 | -34.261 | -22.602 | -28.153 | -20.832 | -9.829 | -0.862 | -7.199 | -6.329 | -1.019 | -2.409 |
| EBITDA Ratio
| -0.408 | -0.832 | -3.917 | -1.919 | -254.689 | -96.413 | -51.626 | -120.387 | -114.66 | -56.46 | -3.389 | -0.756 | -1.559 | -1.261 | -1.911 | -3.667 | -14.675 | -6.416 | -23.901 | -16.357 | -1.283 | -0.072 | -1.359 | -7.011 | -0.75 | -3.083 |